You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
With a focus on practical patient related issues, Autoimmune Hepatitis: A Guide for Practicing Clinicians serves as a useful practical, and much needed, resource for all those physicians presented with managing patients diagnosed with autoimmune hepatitis, both acutely and over the long term. It provides a basis for clinicians to understand the etiology of the disease, as well as special circumstances where management dilemmas often arise. Emphasis is given to providing management advice of immediate use to clinicians, something not presently offered by other larger general texts. The chapters are written by those with an expertise and training in this field and include the most up to date information. The book will be of great value to Gastroenterologists, Hepatologists, and Internists at all levels who see patients presenting with autoimmune hepatitis.
Taking her title from an ancient Greek belief that women's health problems were caused by "a wandering uterus" that needed to be confined and controlled, Meyer exposes the way in which myths and prejudice about female sexuality continue to influence the practice of law and medicine. Suitable for undergraduate courses as well as for generally interested reader, this book offers new insights while providing a wealth of up-to-date information. The text follows the reproductive cycle on three main parts: Political Issues of Pre-Conception, the Politics of Pregnancy, and The Politics of Motherhood. Throughout, Meyer argues passionately that, while technology and medicine must progress, they should not be allowed to do so at women's expense.
None
Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV.
None